-
Product Insights
NewCardiac Valve Repair Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac valve repair devices are used in the Open-Heart surgery to repair the malfunctioning of valves. GlobalData's Medical Devices sector report, “Cardiac Valve Repair Devices Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2024 Update" provides comprehensive information about the Cardiac Valve Repair Devices pipeline products with comparative analysis of the products at various stages of development and information about the clinical trials which are in progress. The Cardiac Valve Repair Devices report...
-
Product Insights
Orthodontic Materials and Products Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Orthodontic Materials and Products Pipeline Market Report Overview Orthodontic materials and products are designed to correct teeth and jaws that are positioned improperly. The orthodontic materials and products pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key...
-
Product Insights
Spinal Fusion Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Spinal Fusion Pipeline Market Report Overview Spinal Fusion procedures are mainly performed on the cervical and thoracolumbar regions. Spinal fusion is a surgical procedure that involves joining two vertebrae in the spine to form a single solid bone, with the involvement of certain devices, to relieve pain. Conventional and Minimally Invasive Surgery (MIS) methods are used to perform Spinal Fusion. Conventional methods include all open surgical methods that are used for performing spinal procedures. The Spinal Fusion pipeline market research...
-
Product Insights
Ultrasound Systems Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Ultrasound Systems Pipeline Market Report Overview Ultrasound Systems are devices that make use of sound waves of high frequency to produce images of structures inside the body. Most of the devices use Sonar principles and are placed outside while in a few cases, they are even placed inside of the body. 2D Ultrasound Systems, 3D Ultrasound Systems, Real-Time 3D Ultrasound Systems, and Hand Held Ultrasound (HHU) Systems are tracked under this category. The Ultrasound Systems pipeline market research report provides...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Rifaquizinone in Liver Cirrhosis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rifaquizinone in Liver Cirrhosis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rifaquizinone in Liver Cirrhosis Drug Details: Rifaquizinone is under development for the...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Derazantinib Hydrochloride in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Derazantinib Hydrochloride in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Derazantinib Hydrochloride in Solid Tumor Drug Details: Deranzantinib hydrchloride (ARQ-087)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VENT-03 in Systemic Lupus Erythematosus
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VENT-03 in Systemic Lupus Erythematosus report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VENT-03 in Systemic Lupus Erythematosus Drug Details: VNX-01 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VENT-03 in Systemic Sclerosis (Scleroderma)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VENT-03 in Systemic Sclerosis (Scleroderma) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VENT-03 in Systemic Sclerosis (Scleroderma) Drug Details: VNX-01 is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VENT-03 in Dermatomyositis
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VENT-03 in Dermatomyositis report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VENT-03 in Dermatomyositis Drug Details: VNX-01 is under development for the treatment of...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – VENT-03 in Neuroinflammation
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - VENT-03 in Neuroinflammation report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. VENT-03 in Neuroinflammation Drug Details: VNX-01 is under development for the treatment of...